These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36305356)

  • 1. Serum soluble E-cadherin is a new potential marker for assessing the severity of gout.
    Zhao Q; Xiong Y; Man X; Liu Y; Huang Y; Chen W; Wang B
    Clin Exp Rheumatol; 2023 May; 41(5):1170-1178. PubMed ID: 36305356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble E-cadherin is associated with oxidative stress in patients with chronic HBV infection.
    Yang J; Xiong Y; Zhou L; Huang Y; Chen W; Wang B
    J Med Virol; 2020 Jan; 92(1):34-44. PubMed ID: 31429942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble E-cadherin as a serum biomarker in patients with HBV-related liver diseases.
    Wang B; Liu J; Xiong Y; Yan Y; Sun B; Zhao Q; Duan L; Li P; Huang Y; Chen W
    Clin Biochem; 2016 Nov; 49(16-17):1232-1237. PubMed ID: 27452182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CA72-4 is specifically elevated in gout patients and predicts flares.
    Bai X; Sun M; He Y; Liu R; Cui L; Wang C; Wan F; Wang M; Li X; Li H; Wu X; Li C
    Rheumatology (Oxford); 2020 Oct; 59(10):2872-2880. PubMed ID: 32087013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the relationship between FFA and gout flare.
    Pei L; Xie L; Wu J; Zhang H; Zhang X
    Clin Rheumatol; 2020 Apr; 39(4):1251-1255. PubMed ID: 32016654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms associated with P2X7R function regulate the onset of gouty arthritis.
    Tao JH; Cheng M; Tang JP; Dai XJ; Zhang Y; Li XP; Liu Q; Wang YL
    PLoS One; 2017; 12(8):e0181685. PubMed ID: 28797095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Levels of Serum Uric Acid, Cystain C and Lipids Concentration and their Clinical Significance in Primary Gouty Arthritis Patients.
    Zhang QB; Zhu D; Wen Z; Yi T; Li Q; Qing YF; Zhou JG
    Curr Rheumatol Rev; 2019; 15(2):141-145. PubMed ID: 29984668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between musculoskeletal ultrasonography and bone remodelling markers and its role in disease monitoring of gout and hyperuricaemia.
    Zou Y; Fei Y; Gao H; Xie LF; Zhong YC; Yang QZ; Wang DL; Zhang XW
    Clin Exp Rheumatol; 2020; 38(5):896-902. PubMed ID: 31858958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer.
    Zhu S; Zhao G; Zhao X; Zhan X; Cai M; Geng C; Pu Q; Zhao Q; Fu Q; Huang C; Wang Q
    Gene; 2020 Sep; 754():144899. PubMed ID: 32544494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of gout.
    Grassi W; De Angelis R
    Reumatismo; 2012 Jan; 63(4):238-45. PubMed ID: 22303530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of gout on left atrial volume remodelling: a prospective echocardiographic study.
    Pan KL; Lin JC; Lin CL; Chen MC; Chang PJ; Hsiao JF; Chang ST; Chung CM
    Rheumatology (Oxford); 2014 May; 53(5):867-74. PubMed ID: 24407232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential clinical value of serum interleukin-41 levels in patients with acute gout.
    Zhou Y; Shi S; Meng S; Zhao H; Wu X; Li M; Li Y
    Int Immunopharmacol; 2023 Sep; 122():110621. PubMed ID: 37437433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum soluble E-cadherin in colorectal carcinoma.
    Okugawa Y; Toiyama Y; Inoue Y; Iwata T; Fujikawa H; Saigusa S; Konishi N; Tanaka K; Uchida K; Kusunoki M
    J Surg Res; 2012 Jun; 175(2):e67-73. PubMed ID: 22277332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble E-cadherin in systemic lupus erythematosus.
    Jin T; Almehed K; Zhu Y; Carlsten H; Forsblad-d'Elia H
    J Rheumatol; 2013 Oct; 40(10):1677-82. PubMed ID: 23996289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
    Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
    Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints.
    Melis L; Van Praet L; Pircher H; Venken K; Elewaut D
    Ann Rheum Dis; 2014 Jun; 73(6):1223-31. PubMed ID: 23740233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Energy CT in Patients with Suspected Gouty Arthritis: Effects on Treatment Regimen and Clinical Outcome.
    Metzger SC; Koehm M; Wichmann JL; Buettner S; Scholtz JE; Beeres M; Kerl JM; Albrecht MH; Hammerstingl R; Vogl TJ; Bauer RW
    Acad Radiol; 2016 Mar; 23(3):267-72. PubMed ID: 26749327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axial (spinal) gout.
    Lumezanu E; Konatalapalli R; Weinstein A
    Curr Rheumatol Rep; 2012 Apr; 14(2):161-4. PubMed ID: 22318623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperuricemia and gout].
    Gröbner W
    Dtsch Med Wochenschr; 2015 Oct; 140(21):1615-26. PubMed ID: 26488103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia].
    Tausche AK; Manger B; Müller-Ladner U; Schmidt B
    Z Rheumatol; 2012 Apr; 71(3):224-30. PubMed ID: 22415625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.